When in life we gain weight can have a significant impact on our health many years later. In a study involving over 600,000 ...
Tim Fitzpatrick was at home on Long Island when he saw a local news story about a 13-year-old boy in need of a kidney ...
Late breaking results from the phase III NRG GY019 trial indicate that letrozole monotherapy (L) did not demonstrate non ...
Viruses are masters at invading our cells thanks to specialized proteins that coat their surfaces. When scientists design ...
New findings from researchers at the Marshall University Joan C. Edwards School of Medicine and The Hebrew University of Jerusalem have identified a potential association between COVID-19 and ...
Macrophages, much like Alice of "Alice in Wonderland," recognize and consume tumor cells that display "eat me" surface ...
More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not ...
The Damon Runyon Cancer Research Foundation has named 13 new Damon Runyon Fellows, exceptional postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading ...
Do our norms around sex presentation uphold a constrictive gender regime? In a new article in Ethics, Ophelia Vedder writes that the abolition of hegemonic gender roles must involve the elimination of ...
Humans and most other organisms have internal biological clocks that track the daily cycle of sunrise and sunset. These ...
Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...
Results from a phase 2 clinical trial designed and overseen by researchers at Mass General Brigham Cancer Institute show that the investigational medication mezagitamab can effectively boost platelet ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results